In its Q2 earnings call Thursday, Novartis said it is moving quickly to reshore its drug manufacturing operations, but CEO ...

Swiss drugmaker Novartis nudged up its full-year earnings forecast on Thursday, citing strong second-quarter sales of key ...

By Noreen Marcus, FloridaBulldog.org - Trump’s tariff assault on drug affordability stings a Vero Beach cancer patient ...

In April, Trump announced a 25% tariff on U.S. imports from South Korea as part of his broader “Liberation Day” trade package ...

Early trading on Wall Street was quietly mixed as markets shift their attention toward a deluge of corporate earnings reports ...

U.S. President Donald Trump has announced that China may soon implement the death penalty for those involved in fentanyl ...

Johnson & Johnson (NYSE:JNJ) on Wednesday reported a second-quarter 2025 adjusted earnings of $2.77 per share, down 1.8% year ...

J&J (NYSE:JNJ) stock surges rallying peers despite Trump's latest tariff threats on pharma as the company posts a quarterly ...

Trump has again threatened the multibillion-dollar pharmaceutical sector with high tariffs unless they move production to the U.S.

Shares of Johnson & Johnson climbed 6.8% in morning trading, enough to pace the S&P 500 index's SPX gainers. They were also headed for their biggest one-day gain and best postearnings reaction since ...